An $80,000 grant for The Wistar Institute’s HIV-1 Patient Partnership for Basic Research program from the Robert I. Jacobs Fund of Philadelphia Foundation not only advances ongoing basic research int…
On Friday, February 24, 2023, more than 175 postdoctoral, graduate, and undergraduate students from around Philadelphia came together for the very first Wistar Institute Trainee Research Symposium. T…
Dr. Luis J. Montaner and lab find common, persistent symptoms for long-haulers by reviewing a multitude of research studies. An international team of researchers led by The Wistar Institute’s lead sc…
Some cancers are linked to viral infections. Studying viruses found in tumor cells can reveal important information in the development of more effective cancer treatments. Wistar researchers develope…
What clues can a cell’s death reveal for immunotherapies for treating cancer and other diseases? Wistar scientists Dr. Yulia Nefedova, associate professor in the Immunology, Microenvironment & Me…
The annual award supports early career investigators and their work advancing in the immunology, vaccine, and immunotherapy space. Noam Auslander, Ph.D., Assistant Professor in the Molecular &am…
Heather A. Steinman, Ph.D., M.B.A., joined The Wistar Institute as vice president for business development and executive director of technology transfer in October 2014. Dr. Steinman was hired i…
Predoctoral trainees Alex Indeglia and Pratik Bhojnagarwala are co-recipients of the annual Monica H. M. Shander Memorial Fellowship Award for outstanding predoctoral research. They were presented th…
Wistar’s major accomplishments in 2022 are made possible by the dedicated and innovative scientists, staff, and generous donors committed to improve the health of all through biomedical research. Fro…
In 1979, at the dawn of the biotechnology era, The Wistar Institute was awarded the first of several patents for the production of monoclonal antibodies against tumors and influenza virus antigens, w…
